Citation
Kotańska, Magdalena, et al. "KD-64-A New Selective A2A Adenosine Receptor Antagonist Has Anti-inflammatory Activity but Contrary to the Non-selective antagonist-Caffeine Does Not Reduce Diet-induced Obesity in Mice." PloS One, vol. 15, no. 6, 2020, pp. e0229806.
Kotańska M, Dziubina A, Szafarz M, et al. KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice. PLoS One. 2020;15(6):e0229806.
Kotańska, M., Dziubina, A., Szafarz, M., Mika, K., Reguła, K., Bednarski, M., Zygmunt, M., Drabczyńska, A., Sapa, J., & Kieć-Kononowicz, K. (2020). KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice. PloS One, 15(6), e0229806. https://doi.org/10.1371/journal.pone.0229806
Kotańska M, et al. KD-64-A New Selective A2A Adenosine Receptor Antagonist Has Anti-inflammatory Activity but Contrary to the Non-selective antagonist-Caffeine Does Not Reduce Diet-induced Obesity in Mice. PLoS One. 2020;15(6):e0229806. PubMed PMID: 32555600.
TY - JOUR
T1 - KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice.
AU - Kotańska,Magdalena,
AU - Dziubina,Anna,
AU - Szafarz,Małgorzata,
AU - Mika,Kamil,
AU - Reguła,Karolina,
AU - Bednarski,Marek,
AU - Zygmunt,Małgorzata,
AU - Drabczyńska,Anna,
AU - Sapa,Jacek,
AU - Kieć-Kononowicz,Katarzyna,
Y1 - 2020/06/18/
PY - 2020/02/13/received
PY - 2020/05/27/accepted
PY - 2020/6/20/entrez
PY - 2020/6/20/pubmed
PY - 2020/8/22/medline
SP - e0229806
EP - e0229806
JF - PloS one
JO - PLoS One
VL - 15
IS - 6
N2 - The A2 adenosine receptors play an important role, among others, in the regulation of inflammatory process and glucose homeostasis in diabetes and obesity. Thus, the presented project evaluated of influence of the selective antagonist of A2A adenosine receptor-KD-64 as compared to the known non-selective antagonist-caffeine on these two particular processes. Two different inflammation models were induced namely local and systemic inflammation. Obesity was induced in mice by high-fat diet and the tested compounds (KD-64 and caffeine) were administrated for 21 days. KD-64 showed anti-inflammatory effect in both tested inflammation models and administered at the same dose as ketoprofen exerted stronger effect than this reference compound. Elevated levels of IL-6 and TNF-α observed in obese control mice were significantly lowered by the administration of KD-64 and were similar to the values observed in control non-obese mice. Interestingly, caffeine increased the levels of these parameters. In contrast to caffeine which had no influence on AlaT activity, KD-64 administration significantly lowered AlaT activity in the obese mice. Although, contrary to caffeine, KD-64 did not reduce diet-induced obesity in mice, it improved glucose tolerance. Thus, the activity of the selective adenosine A2A receptor antagonist was quite different from that of the non-selective.
SN - 1932-6203
UR - https://www.unboundmedicine.com/medline/citation/32555600/KD_64_A_new_selective_A2A_adenosine_receptor_antagonist_has_anti_inflammatory_activity_but_contrary_to_the_non_selective_antagonist_Caffeine_does_not_reduce_diet_induced_obesity_in_mice_
DB - PRIME
DP - Unbound Medicine
ER -